Maria Angeles Muñoz Fernandez-rekin lankidetzan egindako argitalpenak (69)

2023

  1. Antibody levels to SARS-CoV-2 spike protein in mothers and children from delivery to six months later

    Birth, Vol. 50, Núm. 2, pp. 418-427

  2. IgG antibody levels against the SARS-CoV-2 spike protein in mother–child dyads after COVID-19 vaccination

    Infection

  3. Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial

    eClinicalMedicine, Vol. 60

2022

  1. Impact of Gestational COVID-19 on Neonatal Outcomes: Is Vertical Infection Possible?

    The Pediatric infectious disease journal, Vol. 41, Núm. 6, pp. 466-472

  2. Nutritional Supplementation to Increase Influenza Vaccine Response in Children Living With HIV: A Pilot Clinical Trial

    Frontiers in Pediatrics, Vol. 10

  3. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

  4. Risk-score based strategy to minimize antibiotic exposure in children with sickle cell disease and fever

    Infection, Vol. 50, Núm. 2, pp. 499-505

  5. Targeting the Gut Microbiota of Vertically HIV-Infected Children to Decrease Inflammation and Immunoactivation: A Pilot Clinical Trial

    Nutrients, Vol. 14, Núm. 5

2021

  1. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  2. Innate and adaptive abnormalities in youth with vertically acquired HIV through a multicentre cohort in Spain

    Journal of the International AIDS Society, Vol. 24, Núm. 10

  3. Interleukin 6 as a marker of severe bacterial infection in children with sickle cell disease and fever: a case–control study

    BMC Infectious Diseases, Vol. 21, Núm. 1

  4. The clinical relevance of the microbiome when managing paediatric infectious diseases—Narrative review

    Acta Paediatrica, International Journal of Paediatrics, Vol. 110, Núm. 2, pp. 441-449

2020

  1. Effect of a Nutritional Intervention on the Intestinal Microbiota of Vertically HIV-Infected Children: The Pediabiota Study

    Nutrients, Vol. 12, Núm. 7

  2. Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study

    AIDS Research and Therapy, Vol. 17, Núm. 1

  3. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

    The Lancet HIV, Vol. 7, Núm. 8, pp. e565-e573

  4. How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain

    HIV Medicine, Vol. 21, Núm. 2, pp. 128-134

2019

  1. Prognostic factors of a lower CD4/CD8 ratio in long term viral suppression HIV infected children

    PLoS ONE, Vol. 14, Núm. 8

  2. Reduced Time to Suppression among Neonates with HIV Initiating Antiretroviral Therapy Within 7 Days after Birth

    Journal of Acquired Immune Deficiency Syndromes, Vol. 82, Núm. 5, pp. 483-490

  3. Sociodemographic changes and trends in the rates of new perinatal HIV diagnoses and transmission in Spain from 1997 to 2015

    PLoS ONE, Vol. 14, Núm. 10

2018

  1. Early and highly suppressive antiretroviral therapy are main factors associated with low viral reservoir in European perinatally HIV-infected children

    Journal of Acquired Immune Deficiency Syndromes